Table 4.
Results of swelling degree, bioactivity assessment, and the test of hemocompatibility. UHA, UHB … ultrasonicated. IHA, IHB … in situ synthesis of HAp.
| SAMPLE | Composition Ratio [PVA/HA/HAp] | Swelling Degree [%] |
Degradation [%] |
Hemolysis 1
[%] |
|---|---|---|---|---|
| UHA | 3:1:2 | 383 ± 54 | 8.4 ± 0.8 | 18.1 ± 1.2 (++) |
| IHA | 3:1:2 | 392 ± 49 | 16.0 ± 0.5 | 21.1 ± 1.0 (+) |
| UHB | 1:1:2 | 211 ± 7 | 15.0 ± 2.7 | 14.7 ± 2.0 (++) |
| IHB | 1:1:2 | 170 ± 24 | 17.2 ± 2.8 | 3.8 ± 0.4 (+++) |
1 Highly hemocompatible (<5 % hemolysis, +++), hemocompatible (within 10 % hemolysis, ++), and non-hemocompatible (>20 % hemolysis, +).